The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction

Conditions: Heart Failure, Preserved Ejection Fraction Interventions: Drug: SGLT2 inhibitor Sponsors: Samsung Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials